These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4469834)

  • 1. [Systemic lupus erythematosus. Our experience related to 18 cases].
    Schiavetti L; Ravetta M; Porzio F; Lanciani P
    Reumatismo; 1974; 26(1):68-75. PubMed ID: 4469834
    [No Abstract]   [Full Text] [Related]  

  • 2. [HLA antigens in systemic lupus erythematosus patients].
    Matveĭkov GP; Levin VI; Dosin IuM; Kaliia ES; Semenov GV
    Ter Arkh; 1984; 56(10):40-4. PubMed ID: 6596770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunobiological aspects of patients with systemic lupus erythematosus and their blood relatives].
    Ionescu R; Popescu E; Ilinca D; Marcu I; Ghiţescu M
    Med Interna; 1992; 44(1):45-52. PubMed ID: 1345350
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.
    Rizzo R; Hviid TV; Govoni M; Padovan M; Rubini M; Melchiorri L; Stignani M; Carturan S; Grappa MT; Fotinidi M; Ferretti S; Voss A; Laustrup H; Junker P; Trotta F; Baricordi OR
    Tissue Antigens; 2008 Jun; 71(6):520-9. PubMed ID: 18380776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disseminated lupus erythematosus].
    Humbert P; Renaud A; Dupond JL
    Soins; 1987 Dec; (507):17-20. PubMed ID: 3438746
    [No Abstract]   [Full Text] [Related]  

  • 6. [The significance of immunogenetic factors in the pathogenesis of systemic lupus erythematosus].
    Matveĭkov GP; Kaliia ES; Dosin IuM; Iagur VE; Levin VI
    Revmatologiia (Mosk); 1988; (4):17-23. PubMed ID: 3073495
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific antibody response after in vivo antigenic stimulation in systemic lupus erythematosus.
    Croft SM; Schiffman G; Snyder E; Herrmann K; James K; Jarrett MP
    J Rheumatol; 1984 Apr; 11(2):141-6. PubMed ID: 6726713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic lupus erythematosus.
    Koffler D
    Sci Am; 1980 Jul; 243(1):40-9. PubMed ID: 6450445
    [No Abstract]   [Full Text] [Related]  

  • 9. [HLA-A and HLA-B antigens in patients with systemic lupus erythematosus].
    Yoshinari NN; Pastor EH; de Oliveira DP; de Oliveira MA; Rosales T; Cordoni R; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(5):208-14. PubMed ID: 6598514
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vascular lesions in the pathogenesis of systemic lupus erythematosus].
    Potekhina RN; Shilkina NP; Poltyrev AS; Romanov VA; Malofeeva ZV
    Vopr Revm; 1981; (2):18-21. PubMed ID: 7324410
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnostic and prognostic significance of indicators of humoral and cellular immunity in patients with lupus erythematosus].
    Konstantinova NA; Koval'chuk LV; Cheredeev AN; Mattess Kh; Trofimova LIa
    Sov Med; 1983; (5):30-4. PubMed ID: 6612458
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current viewpoints on the pathogenesis of lupus erythematosus].
    Sönnichsen N; Haustein UF; Barthelmes H
    Z Arztl Fortbild (Jena); 1971 Jun; 65(12):581-5. PubMed ID: 4939579
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum complements and circulating immune complex in patients with systemic lupus erythematosus].
    Tang HY
    Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):83-6. PubMed ID: 6407735
    [No Abstract]   [Full Text] [Related]  

  • 14. [The major histocompatibility system in man and systemic lupus erythematosus. (SLE). II. HLA antigens in SLE in the Slovak population].
    Bosák V; Zitnan D; Lukác J; Rovenský J; Cebecauer L
    Fysiatr Revmatol Vestn; 1984 Apr; 62(2):65-70. PubMed ID: 6540233
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune complexes and systemic lupus erythematosus.
    Miescher PA
    Folia Allergol (Roma); 1970; 17(4):428. PubMed ID: 5457999
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral lesions in systemic lupus erythematosus. I. The etiopathogenic aspects of lupus erythematosus].
    Bonaccorso A; Tripi TR
    Minerva Stomatol; 1998; 47(1-2):27-31. PubMed ID: 9578644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family studies of B lymphocyte alloantigens in systemic lupus erythematosus.
    Reinersten JL; Klippel JH; Johnson AH; Steinberg AD; Decker JL; Mann DL
    J Rheumatol; 1982; 9(2):253-62. PubMed ID: 6980280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of serum soluble HLA class I antigens in systemic lupus erythematosus.
    Hagihara M; Shimura T; Yamamoto K; Sujirachato K; Tsuji S; Yamamura M; Tsuji K
    Tokai J Exp Clin Med; 1993 Jun; 18(1-2):61-4. PubMed ID: 7940609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological tests in "systemic lupus erythematosus"].
    Szegedi G
    Minerva Med; 1978 Jun; 69(32):2165-76. PubMed ID: 683572
    [No Abstract]   [Full Text] [Related]  

  • 20. [Circulating immune complexes (PEG tests) in systemic lupus erythematosus].
    Ivanova MM; Nasonov EL; Solov'ev SK; Speranskiĭ AI; Sura VV
    Ter Arkh; 1982; 54(6):63-8. PubMed ID: 7112424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.